David Raben, Chief Medical Officer at Bicara Therapeutics Inc. (BCAX), sold 32,800 shares at $18.45 ($607K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $607k BCAX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.45 | 200 | $4K | 0.6% |
| 2 | $18.52 | 16,300 | $302K | 49.7% |
| 3 | $18.52 | 16,300 | $302K | 49.7% |
| Total | $18.52 avg | 32,800 | $607K | 100% |
| Filing → |
| BCAX | SELL | 2025-11-25 | $292K | — | Filing → |
| BCAX | SELL | 2025-10-10 | $406K | — | Filing → |